These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Pharmacologic characteristics of progestins used for contraception and hormone replacement therapy, including new transdermal technologies.
    Author: Burkman RT.
    Journal: Am J Manag Care; 2001 Nov; 7(18 Suppl):S571-4. PubMed ID: 11727395.
    Abstract:
    Structural differences among progestins account for their unique properties. Pharmacologic principles should be used when considering the appropriate progestational agent to achieve both clinical and economic outcomes. Use of the same progestin in oral contraceptives (OCs) and hormone replacement therapy (HRT) allows for a seamless transition from OCs to HRT, while maintaining the health benefits of the OC. A pharmacologically based approach also has been used in developing the first transdermal contraceptive system, which is expected to be on the market in early 2002.
    [Abstract] [Full Text] [Related] [New Search]